INDICATOR_LABEL	INDICATOR_ID	INDICATOR_DESC	MINSET_SERIES	MINSET_SERIES_DESC	REF_AREA	REF_AREA_DESC	SEX	SEX_DESC	TSK_sub_dims	TSK_sub_id	TSK_sub_desc	ISO3	X	Y	UNmember	GEOLEVEL	GEOLEVEL_Desc	SDG_REGION	years	min_year	max_year	N_years	N_years_lag5	N_years_lag10
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	4	Afghanistan	F	Female	SEX	F	Female	AFG	66.02688198	33.83160199	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	4	Afghanistan	M	Male	SEX	M	Male	AFG	66.02688198	33.83160199	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	12	Algeria	F	Female	SEX	F	Female	DZA	2.678164227	28.15940032	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	12	Algeria	M	Male	SEX	M	Male	DZA	2.678164227	28.15940032	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	24	Angola	F	Female	SEX	F	Female	AGO	17.57817062	-12.33724746	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	24	Angola	M	Male	SEX	M	Male	AGO	17.57817062	-12.33724746	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	32	Argentina	F	Female	SEX	F	Female	ARG	-65.14563274	-35.19446255	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	32	Argentina	M	Male	SEX	M	Male	ARG	-65.14563274	-35.19446255	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	36	Australia	F	Female	SEX	F	Female	AUS	134.3499412	-25.57717202	1.0	4	Country or Area	Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	36	Australia	M	Male	SEX	M	Male	AUS	134.3499412	-25.57717202	1.0	4	Country or Area	Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	44	Bahamas	F	Female	SEX	F	Female	BHS	-78.05111663	24.69546597	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	44	Bahamas	M	Male	SEX	M	Male	BHS	-78.05111663	24.69546597	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	48	Bahrain	F	Female	SEX	F	Female	BHR	50.5490754	26.04407747	1.0	4	Country or Area	Northern Africa and Western Asia	[2018]	2018	2018	1	1	1
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	48	Bahrain	M	Male	SEX	M	Male	BHR	50.5490754	26.04407747	1.0	4	Country or Area	Northern Africa and Western Asia	[2018]	2018	2018	1	1	1
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	50	Bangladesh	F	Female	SEX	F	Female	BGD	89.17660788	22.86961622	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	50	Bangladesh	M	Male	SEX	M	Male	BGD	89.17660788	22.86961622	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	51	Armenia	F	Female	SEX	F	Female	ARM	44.93839317	40.29499741	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	51	Armenia	M	Male	SEX	M	Male	ARM	44.93839317	40.29499741	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	52	Barbados	F	Female	SEX	F	Female	BRB	-59.5346489	13.13648273	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	52	Barbados	M	Male	SEX	M	Male	BRB	-59.5346489	13.13648273	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	64	Bhutan	F	Female	SEX	F	Female	BTN	90.45098484	27.39598568	1.0	4	Country or Area	Central and Southern Asia	[2010, 2018]	2010	2018	2	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	64	Bhutan	M	Male	SEX	M	Male	BTN	90.45098484	27.39598568	1.0	4	Country or Area	Central and Southern Asia	[2010, 2018]	2010	2018	2	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	68	Bolivia (Plurinational State of)	F	Female	SEX	F	Female	BOL	-64.66224284	-16.71273412	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	68	Bolivia (Plurinational State of)	M	Male	SEX	M	Male	BOL	-64.66224284	-16.71273412	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	70	Bosnia and Herzegovina	F	Female	SEX	F	Female	BIH	17.78584332	44.16845548	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	70	Bosnia and Herzegovina	M	Male	SEX	M	Male	BIH	17.78584332	44.16845548	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	72	Botswana	F	Female	SEX	F	Female	BWA	23.81380223	-22.18810073	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	72	Botswana	M	Male	SEX	M	Male	BWA	23.81380223	-22.18810073	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	84	Belize	F	Female	SEX	F	Female	BLZ	-88.70199554	17.19965901	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	84	Belize	M	Male	SEX	M	Male	BLZ	-88.70199554	17.19965901	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	100	Bulgaria	F	Female	SEX	F	Female	BGR	25.23763153	42.75731323	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	100	Bulgaria	M	Male	SEX	M	Male	BGR	25.23763153	42.75731323	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	104	Myanmar	F	Female	SEX	F	Female	MMR	96.51752295	21.19332882	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	104	Myanmar	M	Male	SEX	M	Male	MMR	96.51752295	21.19332882	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	108	Burundi	F	Female	SEX	F	Female	BDI	29.89080992	-3.366387428	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	108	Burundi	M	Male	SEX	M	Male	BDI	29.89080992	-3.366387428	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	112	Belarus	F	Female	SEX	F	Female	BLR	28.04940161	53.54193075	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	112	Belarus	M	Male	SEX	M	Male	BLR	28.04940161	53.54193075	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	116	Cambodia	F	Female	SEX	F	Female	KHM	104.922836	12.71163737	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	116	Cambodia	M	Male	SEX	M	Male	KHM	104.922836	12.71163737	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	120	Cameroon	F	Female	SEX	F	Female	CMR	12.7419827	5.692387031	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	120	Cameroon	M	Male	SEX	M	Male	CMR	12.7419827	5.692387031	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	132	Cabo Verde	F	Female	SEX	F	Female	CPV	-23.63544151	15.07791834	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	132	Cabo Verde	M	Male	SEX	M	Male	CPV	-23.63544151	15.07791834	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	140	Central African Republic	F	Female	SEX	F	Female	CAF	20.93559492	7.003720791	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	140	Central African Republic	M	Male	SEX	M	Male	CAF	20.93559492	7.003720791	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	144	Sri Lanka	F	Female	SEX	F	Female	LKA	80.70489654	7.614693343	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	144	Sri Lanka	M	Male	SEX	M	Male	LKA	80.70489654	7.614693343	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	148	Chad	F	Female	SEX	F	Female	TCD	18.66618401	15.36279341	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	148	Chad	M	Male	SEX	M	Male	TCD	18.66618401	15.36279341	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	152	Chile	F	Female	SEX	F	Female	CHL	-71.23029019	-35.2652885	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	152	Chile	M	Male	SEX	M	Male	CHL	-71.23029019	-35.2652885	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	170	Colombia	F	Female	SEX	F	Female	COL	-73.07446751	3.888209046	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	170	Colombia	M	Male	SEX	M	Male	COL	-73.07446751	3.888209046	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	174	Comoros	F	Female	SEX	F	Female	COM	43.34234565	-11.66121732	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	174	Comoros	M	Male	SEX	M	Male	COM	43.34234565	-11.66121732	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	178	Congo	F	Female	SEX	F	Female	COG	15.22052612	-0.840544119	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	178	Congo	M	Male	SEX	M	Male	COG	15.22052612	-0.840544119	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	180	Democratic Republic of the Congo	F	Female	SEX	F	Female	COD	23.65496507	-2.877154732	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	180	Democratic Republic of the Congo	M	Male	SEX	M	Male	COD	23.65496507	-2.877154732	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	188	Costa Rica	F	Female	SEX	F	Female	CRI	-84.19712782	9.970998683	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	188	Costa Rica	M	Male	SEX	M	Male	CRI	-84.19712782	9.970998683	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	191	Croatia	F	Female	SEX	F	Female	HRV	17.95874553	45.45172212	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	191	Croatia	M	Male	SEX	M	Male	HRV	17.95874553	45.45172212	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	192	Cuba	F	Female	SEX	F	Female	CUB	-79.54460144	22.10030366	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	192	Cuba	M	Male	SEX	M	Male	CUB	-79.54460144	22.10030366	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	203	Czechia	F	Female	SEX	F	Female	CZE	15.33151382	49.73913871	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	203	Czechia	M	Male	SEX	M	Male	CZE	15.33151382	49.73913871	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	204	Benin	F	Female	SEX	F	Female	BEN	2.339933594	9.65401646	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	204	Benin	M	Male	SEX	M	Male	BEN	2.339933594	9.65401646	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	208	Denmark	F	Female	SEX	F	Female	DNK	9.326571283	56.03829721	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	208	Denmark	M	Male	SEX	M	Male	DNK	9.326571283	56.03829721	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	214	Dominican Republic	F	Female	SEX	F	Female	DOM	-70.49847576	18.89832088	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	214	Dominican Republic	M	Male	SEX	M	Male	DOM	-70.49847576	18.89832088	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	218	Ecuador	F	Female	SEX	F	Female	ECU	-78.37005241	-1.447785891	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	218	Ecuador	M	Male	SEX	M	Male	ECU	-78.37005241	-1.447785891	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	222	El Salvador	F	Female	SEX	F	Female	SLV	-88.86862995	13.73603564	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	222	El Salvador	M	Male	SEX	M	Male	SLV	-88.86862995	13.73603564	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	226	Equatorial Guinea	F	Female	SEX	F	Female	GNQ	10.46535826	1.565792376	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	226	Equatorial Guinea	M	Male	SEX	M	Male	GNQ	10.46535826	1.565792376	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	231	Ethiopia	F	Female	SEX	F	Female	ETH	39.63505296	8.631223181	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	231	Ethiopia	M	Male	SEX	M	Male	ETH	39.63505296	8.631223181	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	232	Eritrea	F	Female	SEX	F	Female	ERI	38.11074289	16.12894644	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	232	Eritrea	M	Male	SEX	M	Male	ERI	38.11074289	16.12894644	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	233	Estonia	F	Female	SEX	F	Female	EST	25.84093481	58.68487172	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	233	Estonia	M	Male	SEX	M	Male	EST	25.84093481	58.68487172	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	246	Finland	F	Female	SEX	F	Female	FIN	23.308447	61.91586738	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	246	Finland	M	Male	SEX	M	Male	FIN	23.308447	61.91586738	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	250	France	F	Female	SEX	F	Female	FRA	2.457288129	46.62660861	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	250	France	M	Male	SEX	M	Male	FRA	2.457288129	46.62660861	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	262	Djibouti	F	Female	SEX	F	Female	DJI	42.18274707	11.56004161	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	262	Djibouti	M	Male	SEX	M	Male	DJI	42.18274707	11.56004161	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	266	Gabon	F	Female	SEX	F	Female	GAB	11.78727747	-0.60687619	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	266	Gabon	M	Male	SEX	M	Male	GAB	11.78727747	-0.60687619	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	268	Georgia	F	Female	SEX	F	Female	GEO	43.3713615	42.04813028	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	268	Georgia	M	Male	SEX	M	Male	GEO	43.3713615	42.04813028	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	270	Gambia	F	Female	SEX	F	Female	GMB	-15.39944785	13.45295927	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	270	Gambia	M	Male	SEX	M	Male	GMB	-15.39944785	13.45295927	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	276	Germany	F	Female	SEX	F	Female	DEU	10.3806066	51.08862743	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	276	Germany	M	Male	SEX	M	Male	DEU	10.3806066	51.08862743	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	288	Ghana	F	Female	SEX	F	Female	GHA	-1.205623522	7.964825185	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	288	Ghana	M	Male	SEX	M	Male	GHA	-1.205623522	7.964825185	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	320	Guatemala	F	Female	SEX	F	Female	GTM	-91.2312746	15.00273719	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	320	Guatemala	M	Male	SEX	M	Male	GTM	-91.2312746	15.00273719	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	324	Guinea	F	Female	SEX	F	Female	GIN	-11.28173419	11.00210343	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	324	Guinea	M	Male	SEX	M	Male	GIN	-11.28173419	11.00210343	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	328	Guyana	F	Female	SEX	F	Female	GUY	-58.97322037	4.788012784	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	328	Guyana	M	Male	SEX	M	Male	GUY	-58.97322037	4.788012784	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	332	Haiti	F	Female	SEX	F	Female	HTI	-72.33640958	18.40426539	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	332	Haiti	M	Male	SEX	M	Male	HTI	-72.33640958	18.40426539	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	340	Honduras	F	Female	SEX	F	Female	HND	-86.59974381	14.82243161	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	340	Honduras	M	Male	SEX	M	Male	HND	-86.59974381	14.82243161	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	348	Hungary	F	Female	SEX	F	Female	HUN	19.41221519	47.1651448	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	348	Hungary	M	Male	SEX	M	Male	HUN	19.41221519	47.1651448	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	352	Iceland	F	Female	SEX	F	Female	ISL	-19.02116966	64.79134763	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	352	Iceland	M	Male	SEX	M	Male	ISL	-19.02116966	64.79134763	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	360	Indonesia	F	Female	SEX	F	Female	IDN	113.9174	-0.994582204	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	360	Indonesia	M	Male	SEX	M	Male	IDN	113.9174	-0.994582204	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	364	Iran (Islamic Republic of)	F	Female	SEX	F	Female	IRN	54.19766348	32.74370885	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	364	Iran (Islamic Republic of)	M	Male	SEX	M	Male	IRN	54.19766348	32.74370885	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	372	Ireland	F	Female	SEX	F	Female	IRL	-7.121425272	53.25274054	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	372	Ireland	M	Male	SEX	M	Male	IRL	-7.121425272	53.25274054	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	380	Italy	F	Female	SEX	F	Female	ITA	12.57022427	42.79917282	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	380	Italy	M	Male	SEX	M	Male	ITA	12.57022427	42.79917282	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	384	Côte d'Ivoire	F	Female	SEX	F	Female	CIV	-5.552690016	7.62211586	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	384	Côte d'Ivoire	M	Male	SEX	M	Male	CIV	-5.552690016	7.62211586	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	388	Jamaica	F	Female	SEX	F	Female	JAM	-77.31068409	18.15616857	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	388	Jamaica	M	Male	SEX	M	Male	JAM	-77.31068409	18.15616857	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	392	Japan	F	Female	SEX	F	Female	JPN	139.2716103	36.6554539	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	392	Japan	M	Male	SEX	M	Male	JPN	139.2716103	36.6554539	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	398	Kazakhstan	F	Female	SEX	F	Female	KAZ	66.65359159	48.01963494	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	398	Kazakhstan	M	Male	SEX	M	Male	KAZ	66.65359159	48.01963494	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	400	Jordan	F	Female	SEX	F	Female	JOR	37.13024774	30.65365973	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	400	Jordan	M	Male	SEX	M	Male	JOR	37.13024774	30.65365973	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	404	Kenya	F	Female	SEX	F	Female	KEN	37.86096816	0.534797278	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	404	Kenya	M	Male	SEX	M	Male	KEN	37.86096816	0.534797278	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	414	Kuwait	F	Female	SEX	F	Female	KWT	47.49305029	29.53949468	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	414	Kuwait	M	Male	SEX	M	Male	KWT	47.49305029	29.53949468	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	417	Kyrgyzstan	F	Female	SEX	F	Female	KGZ	74.52324839	41.46204516	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	417	Kyrgyzstan	M	Male	SEX	M	Male	KGZ	74.52324839	41.46204516	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	418	Lao People's Democratic Republic	F	Female	SEX	F	Female	LAO	101.9901968	20.27482773	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	418	Lao People's Democratic Republic	M	Male	SEX	M	Male	LAO	101.9901968	20.27482773	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	422	Lebanon	F	Female	SEX	F	Female	LBN	35.89391711	33.92152458	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	422	Lebanon	M	Male	SEX	M	Male	LBN	35.89391711	33.92152458	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	426	Lesotho	F	Female	SEX	F	Female	LSO	28.25362195	-29.58041814	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	426	Lesotho	M	Male	SEX	M	Male	LSO	28.25362195	-29.58041814	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	428	Latvia	F	Female	SEX	F	Female	LVA	26.42461876	56.64196636	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	428	Latvia	M	Male	SEX	M	Male	LVA	26.42461876	56.64196636	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	430	Liberia	F	Female	SEX	F	Female	LBR	-9.311879038	6.448381009	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	430	Liberia	M	Male	SEX	M	Male	LBR	-9.311879038	6.448381009	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	434	Libya	F	Female	SEX	F	Female	LBY	18.0295985	27.04042819	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	434	Libya	M	Male	SEX	M	Male	LBY	18.0295985	27.04042819	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	442	Luxembourg	F	Female	SEX	F	Female	LUX	6.092656563	49.77679538	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	442	Luxembourg	M	Male	SEX	M	Male	LUX	6.092656563	49.77679538	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	450	Madagascar	F	Female	SEX	F	Female	MDG	46.6982339	-19.38514785	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	450	Madagascar	M	Male	SEX	M	Male	MDG	46.6982339	-19.38514785	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	454	Malawi	F	Female	SEX	F	Female	MWI	33.4884625	-13.40819859	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	454	Malawi	M	Male	SEX	M	Male	MWI	33.4884625	-13.40819859	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	458	Malaysia	F	Female	SEX	F	Female	MYS	116.8346314	5.452415309	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	458	Malaysia	M	Male	SEX	M	Male	MYS	116.8346314	5.452415309	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	466	Mali	F	Female	SEX	F	Female	MLI	-3.522016039	17.35311254	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	466	Mali	M	Male	SEX	M	Male	MLI	-3.522016039	17.35311254	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	478	Mauritania	F	Female	SEX	F	Female	MRT	-10.33187259	20.26089546	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	478	Mauritania	M	Male	SEX	M	Male	MRT	-10.33187259	20.26089546	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	480	Mauritius	F	Female	SEX	F	Female	MUS	57.568022	-20.28581998	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	480	Mauritius	M	Male	SEX	M	Male	MUS	57.568022	-20.28581998	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	496	Mongolia	F	Female	SEX	F	Female	MNG	103.0728057	46.83892054	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	496	Mongolia	M	Male	SEX	M	Male	MNG	103.0728057	46.83892054	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	498	Republic of Moldova	F	Female	SEX	F	Female	MDA	28.4650624	47.20236795	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	498	Republic of Moldova	M	Male	SEX	M	Male	MDA	28.4650624	47.20236795	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	499	Montenegro	F	Female	SEX	F	Female	MNE	19.25214024	42.78717043	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	499	Montenegro	M	Male	SEX	M	Male	MNE	19.25214024	42.78717043	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	504	Morocco	F	Female	SEX	F	Female	MAR	-6.281942841	31.8440131	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	504	Morocco	M	Male	SEX	M	Male	MAR	-6.281942841	31.8440131	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	508	Mozambique	F	Female	SEX	F	Female	MOZ	38.18479941	-14.27963886	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	508	Mozambique	M	Male	SEX	M	Male	MOZ	38.18479941	-14.27963886	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	512	Oman	F	Female	SEX	F	Female	OMN	57.87743482	21.98805614	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	512	Oman	M	Male	SEX	M	Male	OMN	57.87743482	21.98805614	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	516	Namibia	F	Female	SEX	F	Female	NAM	17.21907885	-22.13817068	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	516	Namibia	M	Male	SEX	M	Male	NAM	17.21907885	-22.13817068	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	524	Nepal	F	Female	SEX	F	Female	NPL	83.94678863	28.25866332	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	524	Nepal	M	Male	SEX	M	Male	NPL	83.94678863	28.25866332	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	554	New Zealand	F	Female	SEX	F	Female	NZL	170.4755673	-43.98721568	1.0	4	Country or Area	Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	554	New Zealand	M	Male	SEX	M	Male	NZL	170.4755673	-43.98721568	1.0	4	Country or Area	Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	558	Nicaragua	F	Female	SEX	F	Female	NIC	-85.03060315	12.84210839	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	558	Nicaragua	M	Male	SEX	M	Male	NIC	-85.03060315	12.84210839	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	562	Niger	F	Female	SEX	F	Female	NER	9.400167877	17.42143036	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	562	Niger	M	Male	SEX	M	Male	NER	9.400167877	17.42143036	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	566	Nigeria	F	Female	SEX	F	Female	NGA	8.097363256	9.585789025	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	566	Nigeria	M	Male	SEX	M	Male	NGA	8.097363256	9.585789025	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	578	Norway	F	Female	SEX	F	Female	NOR	11.47846389	61.34311134	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	578	Norway	M	Male	SEX	M	Male	NOR	11.47846389	61.34311134	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	586	Pakistan	F	Female	SEX	F	Female	PAK	68.80479684	29.36491634	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	586	Pakistan	M	Male	SEX	M	Male	PAK	68.80479684	29.36491634	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	591	Panama	F	Female	SEX	F	Female	PAN	-81.26616623	8.450965746	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	591	Panama	M	Male	SEX	M	Male	PAN	-81.26616623	8.450965746	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	598	Papua New Guinea	F	Female	SEX	F	Female	PNG	145.8587761	-6.756057077	1.0	4	Country or Area	Oceania, exc. Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	598	Papua New Guinea	M	Male	SEX	M	Male	PNG	145.8587761	-6.756057077	1.0	4	Country or Area	Oceania, exc. Australia and New Zealand	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	600	Paraguay	F	Female	SEX	F	Female	PRY	-60.54854225	-21.70216237	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	600	Paraguay	M	Male	SEX	M	Male	PRY	-60.54854225	-21.70216237	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	604	Peru	F	Female	SEX	F	Female	PER	-71.82093277	-13.58939705	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	604	Peru	M	Male	SEX	M	Male	PER	-71.82093277	-13.58939705	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	608	Philippines	F	Female	SEX	F	Female	PHL	120.8601418	14.16591706	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	608	Philippines	M	Male	SEX	M	Male	PHL	120.8601418	14.16591706	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	620	Portugal	F	Female	SEX	F	Female	PRT	-7.961599811	39.68509315	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	620	Portugal	M	Male	SEX	M	Male	PRT	-7.961599811	39.68509315	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	624	Guinea-Bissau	F	Female	SEX	F	Female	GNB	-14.40182514	12.11760394	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	624	Guinea-Bissau	M	Male	SEX	M	Male	GNB	-14.40182514	12.11760394	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	642	Romania	F	Female	SEX	F	Female	ROU	24.98481009	45.83893563	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	642	Romania	M	Male	SEX	M	Male	ROU	24.98481009	45.83893563	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	646	Rwanda	F	Female	SEX	F	Female	RWA	29.92310194	-1.999842114	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	646	Rwanda	M	Male	SEX	M	Male	RWA	29.92310194	-1.999842114	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	686	Senegal	F	Female	SEX	F	Female	SEN	-14.46636926	14.35920905	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	686	Senegal	M	Male	SEX	M	Male	SEN	-14.46636926	14.35920905	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	688	Serbia	F	Female	SEX	F	Female	SRB	20.805876	44.03145697	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	688	Serbia	M	Male	SEX	M	Male	SRB	20.805876	44.03145697	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	694	Sierra Leone	F	Female	SEX	F	Female	SLE	-11.78306584	8.568604164	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	694	Sierra Leone	M	Male	SEX	M	Male	SLE	-11.78306584	8.568604164	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	703	Slovakia	F	Female	SEX	F	Female	SVK	19.48495604	48.70741446	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	703	Slovakia	M	Male	SEX	M	Male	SVK	19.48495604	48.70741446	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	704	Viet Nam	F	Female	SEX	F	Female	VNM	105.802499	10.09643079	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	704	Viet Nam	M	Male	SEX	M	Male	VNM	105.802499	10.09643079	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	706	Somalia	F	Female	SEX	F	Female	SOM	46.20367477	4.406485729	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	706	Somalia	M	Male	SEX	M	Male	SOM	46.20367477	4.406485729	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	710	South Africa	F	Female	SEX	F	Female	ZAF	24.67184355	-29.99957544	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	710	South Africa	M	Male	SEX	M	Male	ZAF	24.67184355	-29.99957544	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	716	Zimbabwe	F	Female	SEX	F	Female	ZWE	29.86909584	-19.00075492	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	716	Zimbabwe	M	Male	SEX	M	Male	ZWE	29.86909584	-19.00075492	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	724	Spain	F	Female	SEX	F	Female	ESP	-3.554078296	40.39211472	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	724	Spain	M	Male	SEX	M	Male	ESP	-3.554078296	40.39211472	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	728	South Sudan	F	Female	SEX	F	Female	SSD	30.32618773	7.290839152	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	728	South Sudan	M	Male	SEX	M	Male	SSD	30.32618773	7.290839152	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	729	Sudan	F	Female	SEX	F	Female	SDN	29.95650159	16.02643066	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	729	Sudan	M	Male	SEX	M	Male	SDN	29.95650159	16.02643066	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	740	Suriname	F	Female	SEX	F	Female	SUR	-55.90626394	4.132603197	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	740	Suriname	M	Male	SEX	M	Male	SUR	-55.90626394	4.132603197	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	748	Eswatini	F	Female	SEX	F	Female	SWZ	31.50149288	-26.56471011	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	748	Eswatini	M	Male	SEX	M	Male	SWZ	31.50149288	-26.56471011	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	760	Syrian Arab Republic	F	Female	SEX	F	Female	SYR	38.50466565	35.01676176	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	760	Syrian Arab Republic	M	Male	SEX	M	Male	SYR	38.50466565	35.01676176	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	762	Tajikistan	F	Female	SEX	F	Female	TJK	69.294998	38.43069666	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	762	Tajikistan	M	Male	SEX	M	Male	TJK	69.294998	38.43069666	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	764	Thailand	F	Female	SEX	F	Female	THA	101.0202951	15.13089239	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	764	Thailand	M	Male	SEX	M	Male	THA	101.0202951	15.13089239	1.0	4	Country or Area	Eastern and South-Eastern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	768	Togo	F	Female	SEX	F	Female	TGO	0.97835765	8.532096072	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	768	Togo	M	Male	SEX	M	Male	TGO	0.97835765	8.532096072	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	788	Tunisia	F	Female	SEX	F	Female	TUN	9.572737411	34.11439971	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	788	Tunisia	M	Male	SEX	M	Male	TUN	9.572737411	34.11439971	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	800	Uganda	F	Female	SEX	F	Female	UGA	32.39100438	1.279557331	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	800	Uganda	M	Male	SEX	M	Male	UGA	32.39100438	1.279557331	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	804	Ukraine	F	Female	SEX	F	Female	UKR	31.40270802	49.00735945	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	804	Ukraine	M	Male	SEX	M	Male	UKR	31.40270802	49.00735945	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	807	North Macedonia	F	Female	SEX	F	Female	MKD	21.7007909	41.60048068	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	807	North Macedonia	M	Male	SEX	M	Male	MKD	21.7007909	41.60048068	1.0	4	Country or Area	Europe and Northern America	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	818	Egypt	F	Female	SEX	F	Female	EGY	29.77468534	26.57438204	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	818	Egypt	M	Male	SEX	M	Male	EGY	29.77468534	26.57438204	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	834	United Republic of Tanzania	F	Female	SEX	F	Female	TZA	34.80521182	-6.265332606	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	834	United Republic of Tanzania	M	Male	SEX	M	Male	TZA	34.80521182	-6.265332606	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	854	Burkina Faso	F	Female	SEX	F	Female	BFA	-1.742843829	12.27491081	1.0	4	Country or Area	Sub-Saharan Africa	[2010, 2018]	2010	2018	2	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	854	Burkina Faso	M	Male	SEX	M	Male	BFA	-1.742843829	12.27491081	1.0	4	Country or Area	Sub-Saharan Africa	[2010, 2018]	2010	2018	2	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	858	Uruguay	F	Female	SEX	F	Female	URY	-56.01387025	-32.8002838	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	858	Uruguay	M	Male	SEX	M	Male	URY	-56.01387025	-32.8002838	1.0	4	Country or Area	Latin America and the Caribbean	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	860	Uzbekistan	F	Female	SEX	F	Female	UZB	63.11944558	41.77560518	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	860	Uzbekistan	M	Male	SEX	M	Male	UZB	63.11944558	41.77560518	1.0	4	Country or Area	Central and Southern Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	887	Yemen	F	Female	SEX	F	Female	YEM	45.22389143	15.22242099	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	887	Yemen	M	Male	SEX	M	Male	YEM	45.22389143	15.22242099	1.0	4	Country or Area	Northern Africa and Western Asia	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	894	Zambia	F	Female	SEX	F	Female	ZMB	27.850329	-14.59701056	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	894	Zambia	M	Male	SEX	M	Male	ZMB	27.850329	-14.59701056	1.0	4	Country or Area	Sub-Saharan Africa	[2000, 2010, 2018]	2000	2018	3	1	2
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	528	Netherlands	M	Male	SEX	M	Male	NLD	5.331480568	51.86728884	1.0	4	Country or Area	Europe and Northern America	[2000, 2010]	2000	2010	2	0	1
III.9	121f0e02	Access to anti-retroviral drug, by sex	121f0e02	Access to anti-retroviral drug, by sex	528	Netherlands	F	Female	SEX	F	Female	NLD	5.331480568	51.86728884	1.0	4	Country or Area	Europe and Northern America	[2000, 2010]	2000	2010	2	0	1
